TRANSCEND FL is a global trial assessing the efficacy and safety of the CAR T cell therapy lisocabtagene maraleucel in patients with relapsed or refractory follicular lymphoma. Join Dr. Kamdar, the lead investigator for this trial at University of Colorado Cancer Center, for this podcast to learn more. Feel free to email me with thoughts or questions on this podcast at [email protected].

For additional CAR T resources, see below.

HealthTree University:

• What is CAR-T therapy and how is this drug class used to treat follicular lymphoma? 
• What is some of the most promising research being done for follicular lymphoma?
• What are my options for treating follicular lymphoma?                

News Articles:

• Liso-cel CAR T-Cell Therapy
• CAR T-cell Therapy for Follicular Lymphoma 

101 Pages:

• What are the Treatments for Follicular Lymphoma?